The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.50
Bid: 265.00
Ask: 280.00
Change: 2.00 (0.74%)
Spread: 15.00 (5.66%)
Open: 275.00
High: 275.00
Low: 272.00
Prev. Close: 270.00
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Group Chief Executive Officer

6 Jun 2023 07:00

RNS Number : 7195B
Team17 Group PLC
06 June 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. 

 

6 June 2023

 

Team17 Group plc

("Team17", the "Group" or the "Company")

 

Appointment of Group Chief Executive Officer

 

Team17 Group plc, a global games label, creative partner, developer and publisher of independent ("indie") premium video games, educational entertainment apps for children, and working simulation games, is pleased to announce the appointment of Steve Bell as Chief Executive Officer. Steve will join the Board on 4 September 2023 as Group Chief Executive Officer Designate, formally assuming the role of Group Chief Executive Officer from 1 January 2024.

 

Debbie Bestwick MBE will continue in the role of Group Chief Executive Officer until 31 December 2023, working closely with Steve in the initial months of his appointment to ensure a smooth transition and hand over and as previously announced, will then join the Board as a Non-Executive Director on 1 January 2024.

 

Steve joins from Iris Worldwide Holdings Limited ("Iris"), a global integrated marketing agency specialising in brand and digital marketing strategy, which he co-founded in 1999. Steve has amassed extensive digital marketing expertise, having held senior leadership roles since co-founding Iris in 1999, including the role of Global Group Chief Executive since 2021. Managing over 1000 employees in 14 offices around the world, Steve has overseen Iris' work with some of the biggest, most creatively driven and technologically advanced global brands and has been instrumental in developing and delivering Iris' commercial and M&A strategies  

 

Prior to co-founding Iris, Steve worked for the advertising and retail agency Arc Worldwide, spending over five years working across a number of high-profile integrated accounts.

 

Chris Bell, Non-Executive Group Chair, commented: 

 

"We are delighted to have attracted a candidate of Steve's calibre to Team17. Having worked with some of the world's leading brands, Steve brings a wealth of commercial and digital marketing experience to Team17, and we look forward to leveraging this expertise as Team17 moves forward to its next stage of growth."

 

Debbie Bestwick MBE, Group Chief Executive Officer, commented:

 

"As a Board, we have run a rigorous process to find a new Group Chief Executive and we are delighted to announce Steve as my successor. Steve's experience as a co-founder of a people-centric business means he understands the importance of our vibrant and inclusive company culture which remains the cornerstone of everything we do across the Group. I look forward to working with Steve through the handover process, and to supporting him and the broader team thereafter in my role as a Non-Executive Director."

 

Steve Bell, Group Chief Executive Officer Designate, said:

 

"I am thrilled to be joining Team17. The Company has an incredible track record and I'm excited to help build on the Group's strong foundations to continue its impressive growth trajectory. I look forward to working closely with the Board, Mark (CFO), Michael, Julia, Tim and Emmet - the Group's divisional CEO's and their broader teams to bring even more compelling games and apps to players, alongside driving further momentum by supporting the Group's successful organic and acquisitive growth strategy."

 

Additional information on Steve Bell

 

Stephen ("Steve") Alan Bell, aged 50, holds or has held in the past five years the following directorships or partnerships:

 

Current

Past (5 years)

Lingfield College

Iris Partners LLP

Iris Digital Limited*

Pricing Solutions (UK) Limited

Iris Ventures 1 Limited*

Iris Worldwide San Diego Inc.

Iris Ventures (Worldwide) Limited*

Iris Nation Worldwide Limited*

Iris Worldwide Holdings Limited*

Founder Partners Limited*

Iris London Limited*

Iris Promotional Marketing Ltd*

Holdings BR185 Limited*

Iris Amsterdam B.V.*

Iris Germany GmbH*

Iris Americas Inc.*

Iris USA Inc.*

Pepper NA Inc.*

Iris Atlanta Inc.*

 

* will terminate on 30 June 2023

 

Save as disclosed above, Mr Bell has confirmed that there is no further information required to be disclosed pursuant to Schedule 2, paragraph (g) of the AIM Rules for Companies.

 

Enquiries:

 

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Mark Crawford, Chief Financial Officer

 

via Vigo Consulting

 

Houlihan Lokey (Nominated Adviser)

Adrian Reed / Tim Richardson

 

+44 (0)161 250 3577

Berenberg (Broker)

Ben Wright / Toby Flaux / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Fiona Hetherington / Kate Kilgallen

team17@vigoconsulting.com 

+44 (0)20 7390 0233

 

About Team17

 

Team17 Group plc is a global provider of games entertainment to a broad audience. The Group now includes a games entertainment label and creative partner for indie developers, a leading developer and publisher of educational apps targeting children under the age of eight, and a leading working simulation games developer and publisher.

 

 Visit www.team17groupplc.com/  for more info.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFAMPTMTBMBRJ
Date   Source Headline
16th Apr 20247:00 amRNSUnaudited Final Results 2023
12th Apr 20241:16 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSNotice of Analyst & Investor Meetings, FY Results
19th Mar 20243:29 pmRNSHoldings in Company
13th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 20248:58 amRNSNotice of Results
14th Feb 20241:00 pmRNSDirector/PDMR Shareholding
13th Feb 20244:28 pmRNSDirector/PDMR Shareholding
1st Feb 20241:10 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading Update
19th Jan 20243:01 pmRNSHolding(s) in Company
12th Jan 20244:53 pmRNSHolding(s) in Company
12th Jan 20243:04 pmRNSHolding(s) in Company
11th Jan 20243:23 pmRNSDirector/PDMR Shareholding
14th Dec 20239:15 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSDirector Dealings
27th Nov 20237:00 amRNSDirector Dealings
24th Nov 20237:00 amRNSTrading Update
15th Nov 20233:29 pmRNSHolding(s) in Company
13th Nov 20234:57 pmRNSDirector/PDMR Shareholding
30th Oct 20233:51 pmRNSHolding(s) in Company
18th Oct 202312:41 pmRNSHolding(s) in Company
11th Oct 20235:14 pmRNSDirector/PDMR Shareholding
21st Sep 20231:06 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.